AVI BIOPHARMA INC (AVII) has 39 open-market insider trades by 10 insiders since 2006. The most active filer is Leslie Hudson, Former CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Capital Management Llc/ca Eastbourne | 10% | — | 2 | $5.6M | 2010-03-04 |
| George Weaver Haywood | — | — | 8 | $4.4M | 2009-08-25 |
| Leslie Hudson | Former CEO | — | 10 | $2.9M | 2010-07-30 |
| Nishan Garabedian Christopher | Pres | — | 2 | $369K | 2012-04-24 |
| Anthony R. Chase | Dir | — | 5 | $328K | 2011-09-13 |
| Ben Gil Price | Dir | — | 7 | $182K | 2012-03-14 |
| M. Kathleen Behrens | Dir | — | 1 | $150K | 2011-06-21 |
| Jack L. Bowman | Dir | — | 1 | $32K | 2006-03-17 |
| J. David Boyle II | CEO | — | 2 | $23K | 2010-08-27 |
| Ryszard Kole | SVP/Discovery Research | — | 1 | $6K | 2009-02-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ben Gil Price | Director | Buy | $39K | 2012-03-14 |
| Nishan Garabedian Christopher | President | Buy | $174K | 2011-12-15 |
| Anthony R. Chase | Director | Buy | $24K | 2011-09-13 |
| M. Kathleen Behrens | Director | Buy | $150K | 2011-04-06 |
| Ben Gil Price | Director | Buy | $30K | 2011-04-06 |
| Nishan Garabedian Christopher | President | Buy | $195K |
Companies that share insiders with AVII, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2011-04-06 |
| J. David Boyle II | CEO | Buy | $11K | 2010-08-27 |
| Ben Gil Price | Director | Buy | $8K | 2010-08-13 |
| Leslie Hudson | Former CEO | Sell | $354K | 2010-07-30 |
| Leslie Hudson | Former CEO | Sell | $334K | 2010-07-28 |
| Leslie Hudson | Former CEO | Sell | $246K | 2010-07-26 |
| Leslie Hudson | Former CEO | Sell | $370K | 2010-07-23 |
| Leslie Hudson | Former CEO | Sell | $478K | 2010-07-22 |
| Leslie Hudson | Former CEO | Sell | $188K | 2010-07-16 |
| Leslie Hudson | Former CEO | Sell | $316K | 2010-07-09 |